Revenue
55.2 million USD
2026 Q3 · USD
Exact inputs and evidence
- Revenue: 55186000 USD Source
Market value
$1.45B
89,522,897 shares as of 2026-10-30, at $16.17 a share (XZO, IEX close on 2026-11-12) Primary-source evidence
Annual consolidated revenue for 2025: about USD 217M, using the latest reported figures. The previous period, 2024, was about USD 133.9M.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
Window: transactions dated on or after 2025-11-17.
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
55.2 million USD
2026 Q3 · USD
47.39%
2026 Q3 · %
31.7 million USD
2026 Q3 · USD
116404000 USD
89715825 shares
8.38% · 6.94 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
222 million USD
2025-10-01 – 2026-09-30
88 million USD
2025-10-01 – 2026-09-30
83.9 million USD
2025-10-01 – 2026-09-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-11-05.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 133.95 million
–
Current period
USD 216.98 million
–
216980000 − 133948000 = 83032000 USD
133948000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source216980000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 45.32 million
–
Current period
USD 82.75 million
–
82749000 − 45321000 = 37428000 USD
45321000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source82749000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 49.27 million
–
Current period
USD 100.3 million
–
100298000 − 49266000 = 51032000 USD
49266000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source100298000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2023 2023-01-01 – 2023-12-31 | 88333000 | 85779000 Derived | 2554000 | -18908000 Derived | 21462000 | Unavailable | Source
|
| 2024 2024-01-01 – 2024-12-31 | 133948000 | 95931000 Derived | 38017000 | -7304000 Derived | 45321000 | Unavailable | Source
|
| 2025 2025-01-01 – 2025-12-31 | 216980000 | 110990000 Derived | 105990000 | 23241000 Derived | 82749000 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Revenue | 88333000 |
|
| 2024 | Revenue | 133948000 |
|
| 2025 | Revenue | 216980000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Year over year | No prior comparable period |
|
| 2024 | Year over year | 51.6% |
|
| 2025 | Year over year | 62% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Operating margin | 2.9% |
|
| 2024 | Operating margin | 28.4% |
|
| 2025 | Operating margin | 48.8% |
|
| 2023 | Net margin | 24.3% |
|
| 2024 | Net margin | 33.8% |
|
| 2025 | Net margin | 38.1% |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Operating cash flow | 10153000 |
|
| 2024 | Operating cash flow | 49266000 |
|
| 2025 | Operating cash flow | 100298000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023-12-31 | Liabilities / assets | Not reported | No source recorded |
| 2024 | Liabilities / assets | 82.7% |
|
| 2025 | Liabilities / assets | 26.9% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2024 | Current assets / current liabilities | 1.19× |
|
| 2025 | Current assets / current liabilities | 3.86× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2023 2023-01-01 – 2023-12-31 | USD 21.46 million Exact valueExact value: 21462000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 10.15 million Exact valueExact value: 10153000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | USD 45.32 million Exact valueExact value: 45321000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 49.27 million Exact valueExact value: 49266000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | USD 82.75 million Exact valueExact value: 82749000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 100.3 million Exact valueExact value: 100298000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
10 filings · 629 latest values · 629 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001873951, 1873951, XZO, edgar:1873951
Also known as Exzeo Group, Inc., TypTap Insurance Group, Inc.